Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Ozd

2 clinical trials in Ozd, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ozd at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Ozd

Open in trial search

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:VMX-C001
  • Sponsor:VarmX B.V.

Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Protein C
  • Sponsor:Takeda Development Center Americas Inc.

Other cities in Hungary

The busiest research cities in the country

All 71 cities in Hungary

Clinical research in Ozd

What the registry says about research in the country

01 Hematology & Emergency Medicine

Research focusing on Factor Xa inhibitor reversal in urgent medical situations, evaluating innovative approaches for managing anticoagulation in emergency settings.

  • Anticoagulation Management
  • Emergency Surgery Protocols
  • Bleeding Risk Management

These trials aim to enhance patient safety during urgent surgical procedures for individuals on blood thinners.

02 Respiratory Medicine

Innovative research into treating severe community-acquired pneumonia, testing new therapeutic approaches to improve patient outcomes.

  • Pneumonia Treatment
  • Respiratory Infections
  • Critical Care Medicine

Studies focus on reducing mortality rates in severe pneumonia cases through novel immunological interventions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.